Skip to main content
PW Medtech Group Limited logo

PW Medtech Group Limited — Investor Relations & Filings

Ticker · 1358 ISIN · KYG7306W1087 LEI · 894500L18EYHNJR6VJ41 HKEX Manufacturing
Open in API
Filings indexed 789 across all filing types
Latest filing 2016-08-30 Interim / Quarterly Rep…
Country KY Cayman Islands
Listing HKEX 1358

About PW Medtech Group Limited

http://www.pwmedtech.com

PW Medtech Group Limited is a medical device company engaged in the research, development, production, and sale of advanced infusion therapy products. The company's core portfolio includes specialized infusion sets and related accessories, such as non-PVC and DEHP-free infusion systems, precision filter infusion sets, light-resistant infusion sets, and safety IV catheters. Operating primarily in China, India, the Americas, and Africa, the Group emphasizes patient and clinician safety. Key innovations include positive pressure needleless connectors designed to prevent blood backflow and contamination, and safety-engineered devices utilizing double-layer tubing (TPU/PVC) and high-precision filtration to mitigate needlestick injuries and adverse infusion reactions.

Recent filings

Filing Released Lang Actions
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2016
Interim / Quarterly Report Classification · 100% confidence The document is titled 'INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2016' and contains detailed unaudited consolidated financial results, including income statement, balance sheet, statement of changes in equity, and cash flows for the six-month period ending June 30, 2016. It references preparation in accordance with HKAS 34 'Interim financial reporting' and includes comparative figures for the prior period. The document is approximately 15,000 characters long, indicating it is a full report rather than a brief announcement. The content and structure clearly identify it as a comprehensive interim financial report for a period shorter than a full fiscal year, consistent with the definition of an Interim / Quarterly Report (IR). H1 2016
2016-08-30 English
DATE OF BOARD MEETING
Regulatory Filings Classification · 95% confidence The document is an announcement from PW Medtech Group Limited about the date of a board meeting scheduled to approve the unaudited consolidated interim results for the six months ended 30 June 2016 and to consider the payment of an interim dividend. The document does not contain the actual interim financial results or detailed financial data, but rather informs about the upcoming board meeting where such results will be approved and announced. The document length is short (1392 characters) and it is clearly an announcement of a meeting related to interim results, not the interim report itself. According to the rules, such announcements are classified as Regulatory Filings (RNS) because they do not contain substantive financial data or the report itself, but are regulatory announcements about corporate events.
2016-08-18 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 100% confidence The document is a Next Day Disclosure Return for a Main Board listed issuer, PW Medtech Group Limited, detailing changes in issued share capital and share buybacks. It includes specific data on share cancellations and repurchases, references to Listing Rules of the Hong Kong Stock Exchange, and confirms compliance with repurchase rules. This type of document is a regulatory disclosure about share capital changes and share buybacks, not a full financial report or earnings release. It fits the category of Transaction in Own Shares (POS), which covers reports of the company buying back or selling its own shares.
2016-08-09 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JULY 2016
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 31/07/2016, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorised and issued share capital, including share options, warrants, convertibles, and other share capital changes. The content focuses on share capital changes and movements rather than financial performance, earnings, or management commentary. It is a regulatory filing reporting share capital movements for a specific month, not an annual or quarterly report, earnings release, or management discussion. The document is a formal regulatory submission about share capital changes, fitting the category of Major Shareholding Notification or Share Issue/Capital Change. Since it reports movements in issued and authorised share capital, including share options and repurchases, it aligns best with Share Issue/Capital Change (SHA).
2016-08-02 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 95% confidence The document is a Next Day Disclosure Return for a Main Board listed issuer, PW Medtech Group Limited, detailing changes in issued share capital and share buybacks. It includes specific data on share repurchases, dates, prices, and confirmations that the repurchases comply with Listing Rules. The document is regulatory in nature, reporting share capital changes and repurchase activities as required by stock exchange rules. It is not a full financial report, earnings release, or management discussion, but a formal disclosure of share capital changes and share buybacks. This fits the definition of a Transaction in Own Shares (POS) filing, which covers company buybacks or sales of its own shares. The document length (6423 characters) and detailed transactional data support this classification with high confidence.
2016-07-29 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 100% confidence The document is a disclosure return related to changes in issued share capital and share buybacks by PW Medtech Group Limited. It includes detailed information on share repurchases, dates, quantities, and prices, as well as confirmations that the repurchases comply with listing rules. The document is a regulatory disclosure about share capital changes and share repurchases, not a financial report or earnings release. It fits the category of Transaction in Own Shares (POS), which covers reports of the company buying back or selling its own shares.
2016-07-26 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.